NCT06334588

Brief Summary

The main goal of this study is to investigate anatomo-functional brain abnormalities associated with autism spectrum disorders using a multimodal brain imaging approach, as well as its links to social cognition difficulties measured using eye-tracking

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
60mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Apr 2024Apr 2031

First Submitted

Initial submission to the registry

February 22, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 28, 2024

Completed
20 days until next milestone

Study Start

First participant enrolled

April 17, 2024

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2029

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2031

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

5 years

First QC Date

February 22, 2024

Last Update Submit

December 17, 2025

Conditions

Keywords

Autism spectrum disordersMultimodal brain imagingEye-trackingSocial perceptionGeneticsDevelopmental trajectory

Outcome Measures

Primary Outcomes (1)

  • Rest cerebral blood flow (CBF)

    Whole brain rest CBF measured with Arterial spin labelling MRI

    at inclusion

Secondary Outcomes (13)

  • Measurements of white matter microstructure - fractional anisotropy

    at inclusion

  • Measurements of white matter microstructure - mean diffusivity

    at inclusion

  • Measurements of white matter microstructure - radial diffusivity

    at inclusion

  • Measurements of white matter microstructure - axial diffusivity

    at inclusion

  • Measurements of resting state functional connectivity

    at inclusion

  • +8 more secondary outcomes

Study Arms (3)

Suspected or confirmed Autism Spectrum Disorders (ASD)

EXPERIMENTAL

Patient with ASD or suspected ASD for whom an MRI is requested by the clinician as part of care

Diagnostic Test: MRIDevice: Eye-trackingOther: Clinical ScalesGenetic: Research of genetic anomalies

Healthy volunteers over 3 years of age

EXPERIMENTAL

Healthy Control Children will be recruited specifically for the research

Diagnostic Test: MRIDevice: Eye-trackingOther: Clinical Scales

Healthy volunteers under 5 years of age

NO INTERVENTION

Children who have already undergone an MRI for various medical reasons and whose MRI was normal.

Interventions

MRIDIAGNOSTIC_TEST

Anatomical and functional images will be acquired and review by an experienced neuro-radiologist

Healthy volunteers over 3 years of ageSuspected or confirmed Autism Spectrum Disorders (ASD)

Eye movements and follow a person's gaze will be recorded during visualization of stimuli presented in the screen by analyzing images of the eye captured by an infrared camera

Healthy volunteers over 3 years of ageSuspected or confirmed Autism Spectrum Disorders (ASD)

CGI, E-CAR and ABC will be used for behavior and clinical evaluation

Healthy volunteers over 3 years of ageSuspected or confirmed Autism Spectrum Disorders (ASD)

For the diagnosis of autism, patients benefit from a a genetic assessment. This is carried out as part of their care

Suspected or confirmed Autism Spectrum Disorders (ASD)

Eligibility Criteria

Age3 Months - 28 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • For subjects diagnosed with ASD or suspected of ASD :
  • months ≤ age \< 25 years ;
  • an MRI required as part of the clinical procedures
  • written consent obtained from parents or legal guardians.
  • Affiliated to social security
  • For Healthy control subjects over 3 years of age:
  • between 3 and 28 years of age
  • no known neurological or psychiatric pathology
  • written consent obtained from parents or legal guardian.
  • Affiliated to social security
  • For Healthy control subjects under 5 years of age:
  • age between 3 months and 5 years
  • who have had an MRI scan in the pediatric radiology department at Necker Hospital, which was found to be normal.
  • with no known neurological or psychiatric pathology
  • no opposition from legal representative

You may not qualify if:

  • Contraindication to MRI (pacemaker, intracorporeal metallic body, claustrophobia).
  • Impossibility for healthy volunteers to remain still during MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Necker Enfants Malades

Paris, 75015, France

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder

Interventions

Eye-Tracking Technology

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Eye Movement MeasurementsDiagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Monica ZILBOVICIUS

    INSERM INSERM ERL "Trajectoires Développementales en Psychiatrie"

    STUDY DIRECTOR

Central Study Contacts

Nathalie BODDAERT, MD, PhD

CONTACT

Victor BRUYERE, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2024

First Posted

March 28, 2024

Study Start

April 17, 2024

Primary Completion (Estimated)

April 1, 2029

Study Completion (Estimated)

April 1, 2031

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations